EUVIMEDEUVIMED entdecken
Crossref

Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated Chemotherapy

Pengfei Yuan, Tianci Zhu, Xiaodie Yan, Wen Liu, Lamei Liu, Xiaoqing Zong, Caiqi Yang, Xinjie Chen, Siying Wei, Yaoqi Wen, Wei Xue, Jian Dai iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c04442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Pengfei Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Departm…. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Tirapazamine, Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Central University Basic Research Fund of China, Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNanoparticlesTirapazamineThrombosisAntineoplastic AgentsAnimalsMiceFemaleHumansCell Line, TumorTumor MicroenvironmentMice, Inbred BALB CMice, Inbred C57BLMelanoma, Experimental

Stichwörter der Autor:innen

ZIF-8cancer immunotherapycell membranehypoxia-activated prodrugthrombosis

Substanzen

TirapazamineAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Department of Biomedical Engineering, Jinan University, Guangzhou 510632, Chi…

ORCID-Profile: Jian Dai

Förderung

  • Central University Basic Research Fund of China
  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Yuan, P., Zhu, T., Yan, X., Liu, W., Liu, L., Zong, X., Yang, C., Chen, X., Wei, S., Wen, Y., Xue, W., & Dai, J. (2025). Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated Chemotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c04442

Vancouver

Yuan P, Zhu T, Yan X, Liu W, Liu L, Zong X, et al. Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated Chemotherapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c04442

BibTeX
@article{Yuan2025,
  author = {Yuan, Pengfei and Zhu, Tianci and Yan, Xiaodie and Liu, Wen and Liu, Lamei and Zong, Xiaoqing and Yang, Caiqi and Chen, Xinjie and Wei, Siying and Wen, Yaoqi and Xue, Wei and Dai, Jian},
  title = {Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated Chemotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c04442}
}
Kostenlos starten →